Zealand Pharma A/S (ZEAL) — Capital Reinvestment Ratio
Latest as of June 2025:
0.00x
Zealand Pharma A/S (ZEAL) has a Capital Reinvestment Ratio of 0.00x as of June 2025, meaning it reinvests 0% of its operating cash flow (Dkr8.52 Billion) in capital expenditures (Dkr6.73 Million). See Zealand Pharma A/S free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.00x
Capex / Operating Cash Flow
Operating Cash Flow
Dkr8.52 Billion
DKK
Capital Expenditures
Dkr6.73 Million
DKK
Data as of
Jun 2025
Most recent filing
Zealand Pharma A/S Capital Reinvestment Ratio (2012–2025)
This chart tracks Zealand Pharma A/S's Capital Reinvestment Ratio across 3 annual periods.
Annual Capital Reinvestment Ratio for Zealand Pharma A/S (2012–2025)
Year-by-year Capital Reinvestment Ratio for Zealand Pharma A/S from 2012 to 2025. For live market cap and broader valuation context, see how much is Zealand Pharma A/S worth.
| Year | Reinvestment Ratio | Operating CF (DKK) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.01x | Dkr6.53 Billion | Dkr33.37 Million | ▼ -92.0% |
| 2016 | 0.06x | Dkr40.90 Million | Dkr2.60 Million | ▼ -50.8% |
| 2012 | 0.13x | Dkr68.54 Million | Dkr8.85 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow